Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 19, 2018
Basilea reports receipt of milestone payment based on first Cresemba® approval in Latin America
Basel, Switzerland, July 19, 2018 - Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that it has received a CHF 2 million milestone payment from its partner ...
July 19, 2018
Allakos Announces Pricing of Initial Public Offering
SAN CARLOS, Calif., July 19, 2018 (GLOBE NEWSWIRE) -- Allakos Inc., (ALLK), a clinical stage biotechnology company focused on the development of antibodies for the ...
July 19, 2018
Mustang Bio Completes Pre-IND Meeting with FDA for MB-102 (CD123 CAR T)
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
July 19, 2018
Oncobiologics Completes Exchange of Series A Convertible Preferred Stock for Newly Created Series A-1 Convertible Preferred Stock
CRANBURY, N.J., July 19, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today announced that, on July 18, 2018, the Company completed the exchange of an ...
July 18, 2018
Catalyst Biosciences Announces Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
SOUTH SAN FRANCISCO, Calif., July 18, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
July 18, 2018
Vermillion to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Thursday, August 9
AUSTIN, Texas, July 18, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it will report ...
July 18, 2018
Athenex Announces Axis Therapeutics Has Entered into a MOU with the Hong Kong Polytechnic University to Set Up a Joint Research Center on Cancer Immunotherapy
BUFFALO, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
July 17, 2018
AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares
Lausanne, Switzerland, July 17, 2018 - AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced that it is commencing ...
July 17, 2018
Inspire Medical Systems, Inc. to Report Second Quarter 2018 Financial Results August 7, 2018
MINNEAPOLIS, July 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (“Inspire”) (INSP), a medical technology company focused on the development and commercialization of innovative ...
July 17, 2018
Zosano Announces Positive Data from a Nonclinical Evaluation of Pharmacokinetics and Skin Tolerability Study for ADAM™ Technology for the Delivery of Zolmitriptan
FREMONT, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma (ZSAN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies that deliver rapid ...
July 17, 2018
BrainStorm to Announce Second Quarter Financial Results of 2018 and Provide a Corporate Update on Monday July 23
NEW YORK and PETACH TIKVAH, Israel, July 17, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
July 16, 2018
Neovasc Announces Filing of "Administrative" Prospectus Supplement Relating to Expiry of Prior Shelf Prospectus / Registration Statement
VANCOUVER , July 16, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that, in connection with its new final ...
July 16, 2018
Krystal Biotech to Present Update on KB103 Program for Treatment of Dystrophic Epidermolysis Bullosa at debra Care Conference 2018
PITTSBURGH, July 16, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing topical and intradermal “off-the-shelf” treatments for rare dermatological ...
July 16, 2018
Aeglea BioTherapeutics Appoints Dr. Bryan Lawlis to Board of Directors
AUSTIN, Texas, July 16, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
July 16, 2018
AIT Therapeutics Announces Human and In-Vitro Nitric Oxide (NO) Data Presented at the 3rd Annual World Bronchiectasis Conference
GARDEN CITY, N.Y., and REHOVOT, Israel, July 16, 2018 (GLOBE NEWSWIRE) --  AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
July 12, 2018
New Preclinical Results on Onxeo’s AsiDNA™, First-in-Class DNA Repair Inhibitor, Point to Strong Synergy and Reversion of Tumor Resistance when combined to PARP inhibitors
Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology, in ...
July 12, 2018
Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
EMERYVILLE, Calif., July 12, 2018 (GLOBE NEWSWIRE) --  Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
July 12, 2018
Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis
SOUTH SAN FRANCISCO, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
July 12, 2018
Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors
GAITHERSBURG, Md., July 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company focused on preventing infectious diseases, today announced it has entered ...
July 12, 2018
Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114)
SAN DIEGO, July 12, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE AMERICAN:PFNX) today announced the receipt of a milestone payment from Merck associated with the ...
Page 27 of 117